iPath Pure Beta Livestock ETN
LSTK
LSTK was delisted on the 11th of April, 2018.
3 hedge funds and large institutions have $59K invested in iPath Pure Beta Livestock ETN in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
57% less capital invested
Capital invested by funds: $137K → $59K (-$78K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
LSTK Hedge Fund Activity: Q2 2015 in Review
3 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Livestock ETN (LSTK) for Q2 2015, worth a combined $59K — down 57% from $137K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LSTK and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $16.6K.
- 3 institutional investors held iPath Pure Beta Livestock ETN (LSTK) as of Q2 2015, down from 4 in Q1 2015.
- Funds reported $59K of iPath Pure Beta Livestock ETN stock for Q2 2015, down 57% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Livestock ETN positions in Q2 2015 and 1 closed out, a net change of -1 holder.
- The largest iPath Pure Beta Livestock ETN seller in Q2 2015 was UBS Group, an estimated $16.6K sold.
Based on aggregated 13F filings for Q2 2015.